Ratio of SER012 Neat Stool samples in stock
Number of SER012 Neat Samples per Subject
Ratio of SER013 Neat Stool samples in stock
Number ofSER013 Neat Samples per Subject
Number of SER012 Neat Samples per Subject by label
Number of SER013 Neat Samples per Subject by label
Ratio of SER012 EtOH samples in stock
Number of SER012 EtOH Samples per Subject
Ratio of SER013 EtOH samples in stock
Number of SER013 EtOH Samples per Subject
Number of SER012 EtOH Samples per Subject by label
Number of SER013 EtOH per Subject by label
Ratio of SER013 samples in stock
Number of SER012 Serum Samples per Subject
Ratio of SER013 samples in stock
Number of SER013 Ethanol Samples per Subject
Number of SER012 Serum Samples per Subject by label
Number of SER013 Neat Samples per Subject by label
Number of SER012 Glycerol Samples per Subject
Number of SER013 Glycerol Samples per Subject
Ratio of SER012 Glycerol samples in stock
Ratio of SER013 Glycerol samples in stock
Summary table: SER012
| D1D (N=615) |
D1D-UN1 (N=4) |
D1E (N=152) |
D1E-UN1 (N=2) |
D1F (N=153) |
D1F-UN1 (N=2) |
DUMMY (N=5) |
DUMMY01 (N=2) |
ETA (N=10) |
ETA2 (N=41) |
ETD (N=14) |
Pre-screening (N=33) |
PSCRA (N=118) |
Recurrence Visit (N=46) |
Recurrence Visit2 (N=12) |
Recurrence Visit3 (N=2) |
Recurrence Visit4 (N=1) |
RV1A (N=140) |
RV1A2 (N=508) |
RV1D (N=208) |
RV2A (N=54) |
RV2A2 (N=229) |
RV2D (N=58) |
RV3A (N=14) |
RV3A2 (N=68) |
RV3D (N=9) |
RV4A (N=4) |
RV4A2 (N=9) |
RV4D (N=14) |
RVA (N=10) |
RVD (N=9) |
SCRA (N=103) |
Screeniing (N=92) |
SV2A2 (N=1194) |
Unscheduled Visit (N=9) |
Unscheduled Visit 2 (N=1) |
VA-UN1 (N=52) |
VA-UN2 (N=18) |
VA-UN3 (N=4) |
VA-UN4 (N=2) |
VA2-UN1 (N=123) |
VA2-UN2 (N=24) |
VD-UN1 (N=33) |
VD-UN2 (N=24) |
VD-UN3 (N=9) |
W1A2 (N=1126) |
W24A2 (N=892) |
W2A2 (N=1049) |
W2A2-UN1 (N=8) |
W2D (N=462) |
W8A2 (N=1011) |
W8D (N=578) |
Overall (N=9360) |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SampleGroup_UDF | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 58329_FBMR Serum | 111 (18.0%) | 4 (100%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 4 (28.6%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 49 (23.6%) | 0 (0%) | 0 (0%) | 18 (31.0%) | 0 (0%) | 0 (0%) | 5 (55.6%) | 0 (0%) | 0 (0%) | 3 (21.4%) | 0 (0%) | 4 (44.4%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 8 (24.2%) | 0 (0%) | 4 (44.4%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 94 (20.3%) | 0 (0%) | 106 (18.3%) | 410 (4.4%) |
| 68741_FBMR Serum 5mL | 504 (82.0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 10 (71.4%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 159 (76.4%) | 0 (0%) | 0 (0%) | 40 (69.0%) | 0 (0%) | 0 (0%) | 4 (44.4%) | 0 (0%) | 0 (0%) | 11 (78.6%) | 0 (0%) | 5 (55.6%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 25 (75.8%) | 24 (100%) | 5 (55.6%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 368 (79.7%) | 0 (0%) | 472 (81.7%) | 1627 (17.4%) |
| 58327_Whole Blood - PAXgene DNA | 0 (0%) | 0 (0%) | 152 (100%) | 2 (100%) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (50.0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 155 (1.7%) |
| 58332_Whole Blood - PAXgene RNA | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 153 (100%) | 2 (100%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 155 (1.7%) |
| 58328_EtOH Stool Stock | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 5 (100%) | 0 (0%) | 0 (0%) | 25 (61.0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 8 (5.7%) | 310 (61.0%) | 0 (0%) | 3 (5.6%) | 138 (60.3%) | 0 (0%) | 0 (0%) | 40 (58.8%) | 0 (0%) | 0 (0%) | 5 (55.6%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 737 (61.7%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 75 (61.0%) | 15 (62.5%) | 0 (0%) | 0 (0%) | 0 (0%) | 688 (61.1%) | 488 (54.7%) | 641 (61.1%) | 5 (62.5%) | 0 (0%) | 624 (61.7%) | 0 (0%) | 3807 (40.7%) |
| 58326_C. diff Culture | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (50.0%) | 0 (0%) | 0 (0%) | 0 (0%) | 33 (100%) | 4 (3.4%) | 46 (100%) | 12 (100%) | 2 (100%) | 1 (100%) | 3 (2.1%) | 2 (0.4%) | 0 (0%) | 0 (0%) | 1 (0.4%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 11 (10.7%) | 92 (100%) | 11 (0.9%) | 9 (100%) | 1 (100%) | 2 (3.8%) | 2 (11.1%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 12 (1.1%) | 15 (1.7%) | 15 (1.4%) | 0 (0%) | 0 (0%) | 14 (1.4%) | 0 (0%) | 289 (3.1%) |
| 58330_Glycerol Stool Stock | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 10 (100%) | 0 (0%) | 0 (0%) | 0 (0%) | 114 (96.6%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 122 (87.1%) | 4 (0.8%) | 0 (0%) | 48 (88.9%) | 0 (0%) | 0 (0%) | 14 (100%) | 0 (0%) | 0 (0%) | 4 (100%) | 0 (0%) | 0 (0%) | 10 (100%) | 0 (0%) | 92 (89.3%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 50 (96.2%) | 16 (88.9%) | 4 (100%) | 2 (100%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 490 (5.2%) |
| 58331_Neat Stool Stock | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 16 (39.0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 7 (5.0%) | 192 (37.8%) | 0 (0%) | 3 (5.6%) | 90 (39.3%) | 0 (0%) | 0 (0%) | 28 (41.2%) | 0 (0%) | 0 (0%) | 4 (44.4%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 446 (37.4%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 48 (39.0%) | 9 (37.5%) | 0 (0%) | 0 (0%) | 0 (0%) | 426 (37.8%) | 389 (43.6%) | 393 (37.5%) | 3 (37.5%) | 0 (0%) | 373 (36.9%) | 0 (0%) | 2427 (25.9%) |
Summary table: SER013
| C2RV3A (N=12) |
C2SCRA (N=12) |
C2SVA2 (N=1736) |
C2VA2-UN1 (N=302) |
C2VA2-UN2 (N=79) |
C2W1A2 (N=1109) |
D1D (N=92) |
DUMMY02 (N=12) |
RV1A (N=4) |
RV1A2 (N=77) |
RV1D (N=27) |
RV2A (N=12) |
RV2A2 (N=40) |
RV2D (N=10) |
RV3A2 (N=10) |
RV3D (N=4) |
SCRA-UN1 (N=2) |
SV2A2 (N=155) |
VA2-UN1 (N=30) |
W1A2 (N=210) |
W24A2 (N=180) |
W2A2 (N=240) |
W2D (N=80) |
W8A2 (N=219) |
W8D (N=4) |
Overall (N=4658) |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SampleGroup_UDF | ||||||||||||||||||||||||||
| 68693_EtOH Stool Stock | 6 (50.0%) | 6 (50.0%) | 873 (50.3%) | 153 (50.7%) | 41 (51.9%) | 554 (50.0%) | 0 (0%) | 6 (50.0%) | 0 (0%) | 43 (55.8%) | 0 (0%) | 5 (41.7%) | 20 (50.0%) | 0 (0%) | 5 (50.0%) | 0 (0%) | 0 (0%) | 80 (51.6%) | 15 (50.0%) | 105 (50.0%) | 90 (50.0%) | 120 (50.0%) | 0 (0%) | 110 (50.2%) | 0 (0%) | 2232 (47.9%) |
| 68696_Neat Stool Stock | 6 (50.0%) | 6 (50.0%) | 863 (49.7%) | 149 (49.3%) | 38 (48.1%) | 555 (50.0%) | 0 (0%) | 6 (50.0%) | 0 (0%) | 34 (44.2%) | 0 (0%) | 5 (41.7%) | 20 (50.0%) | 0 (0%) | 5 (50.0%) | 0 (0%) | 0 (0%) | 75 (48.4%) | 15 (50.0%) | 105 (50.0%) | 90 (50.0%) | 120 (50.0%) | 0 (0%) | 109 (49.8%) | 0 (0%) | 2201 (47.3%) |
| 68694_FBMR Serum (or FBMR) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 92 (100%) | 0 (0%) | 0 (0%) | 0 (0%) | 27 (100%) | 0 (0%) | 0 (0%) | 10 (100%) | 0 (0%) | 4 (100%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 80 (100%) | 0 (0%) | 4 (100%) | 217 (4.7%) |
| 68695_Glycerol Stool Stock | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 4 (100%) | 0 (0%) | 0 (0%) | 2 (16.7%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 2 (100%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 8 (0.2%) |